

UK's leading Medical Cannabis Company
Access and care.
Lyphe is UK's most popular cannabis clinical telehealth and dispensing ecosystem.
We own the medical cannabis supply chain vertically.
Our pursuit is for patient access to be mainstream and global.

+130k
Cannabis units despatched
+9k
Patient consultations
35%
UK market share
3x
Digital platforms
No.1
Own label cannabis brand
600
Healthcare professionals trained
Our platforms.



Press room.
25 Aug 2022
Lyphe Group goes down under: UK’s leading medical cannabis clinic expands to other side of the world
Lyphe Group, the UK’s leading medical cannabis clinic, has opened its doors in Australia.The clinic officially opened to the public earlier this month, with a team of experienced medical cannabis professionals at the helm. Already, with just word of mouth and a loyal patient base following the clinic team and doctors, it has over 500 … Continued
Read
23 May 2022
Lyphe Group secures £5m in funding led by Leafy Tunnel
The UK-based medical cannabis ecosystem provider has received funding from Leafy Tunnel, a venture capital fund investing in European medical cannabis and global medical psychedelics companies. Sharp Capital Advisors, a leading US cannabis advisory firm also participated as an investor in the round. The funds are being used for expansion into multiple markets across Europe … Continued
Read
09 Mar 2022
CEO Jonathan Nadler talks UK Medical Cannabis in The Daily Express
Recently, LYPHE Group CEO and Co-Founder Jonathan Nadler spoke to Christopher Sharp at the Daily Express on medical cannabis, the challenges the industry faces and what the next steps need to be. “1.4 million people roughly are consuming illegally for medical reasons. There should be a lot more of those patients that have access … Continued
Read
Proud to stock the best medical cannabis brands in the world.
Contact
For general enquiries please complete the form.
Lyphe Group
20-22 Wenlock Road,
London, N17GU